Zobrazeno 1 - 4
of 4
pro vyhledávání: '"S. V. Kolomentsev"'
Autor:
S. V. Kolomentsev, N. V. Tsygan, I. A. Voznyuk, S. N. Yanishevskiy, E. I. Shermatyuk, O. M. Ilyina, I. V. Litvinenko
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 14, Iss 6, Pp 25-32 (2022)
In-hospital ischemic stroke (IHIS) is one of the most critical competing diseases that can develop in patients during inpatient treatment. Causes associated with diagnostic and therapeutic measures may play an additional role in the pathogenesis of I
Externí odkaz:
https://doaj.org/article/9c7ec40d98604249bad829c22733ef4b
Autor:
Odinak Mm, A V Ryabtsev, S. N. Yanishevsky, Tsygan Nv, I. V. Litvinenko, S. Yu. Golokhvastov, S. V. Kolomentsev, R. V. Andreev
Publikováno v:
"Arterial’naya Gipertenziya" ("Arterial Hypertension"). 27:29-40
The history of reperfusion treatment for ischemic stroke was officially recognized in 1996, when the use of systemic thrombolytic therapy (TLT) was authorized in the United States of America and the first clinical guidelines were published (American
Publikováno v:
Bulletin of Restorative Medicine. 98:90-98
Models of pathogenetic effects of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the new coronavirus infection 2019 (COVID-19) on the brain indicate the possibility of both direct and indirect damage Objective of the research: to study the
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 109(10)
To assess efficacy and tolerability of axamon (ipidacrine) in the complex therapy of patients with cranial-brain injuries, 40 patients have been studied. Patients of the main group (20 persons) received, along with traditional therapy, axamon in dose